Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 629 | 887 | 47,955 | 11,734 | 2,920 |
| Gross Profit | 629 | 887 | 47,955 | 11,734 | 2,920 |
| Operating Expenses | 55,188 | 66,369 | 72,663 | 77,285 | 89,522 |
| Operating Income | -54,559 | -65,482 | -24,708 | -65,551 | -86,602 |
| Interest Expense | 44 | 48 | 57 | 44 | 54 |
| Other Income | 4,360 | 4,877 | 5,876 | 6,700 | 7,473 |
| Pre-tax Income | -50,243 | -60,653 | -18,889 | -58,895 | -79,183 |
| Income Tax | 90 | 172 | 1,265 | 205 | -231 |
| Net Income Continuous | -50,333 | -60,825 | -20,154 | -59,100 | -78,952 |
| Net Income | $-50,333 | $-60,825 | $-20,154 | $-59,100 | $-78,952 |
| EPS Basic Total Ops | -0.72 | -0.87 | -0.29 | -0.85 | -1.14 |
| EPS Basic Continuous Ops | -0.72 | -0.87 | -0.29 | -0.85 | -1.14 |
| EPS Diluted Total Ops | -0.72 | -0.87 | -0.29 | -0.85 | -1.14 |
| EPS Diluted Continuous Ops | -0.72 | -0.87 | -0.29 | -0.85 | -1.14 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -0.87 | -0.29 | -0.85 | -1.14 |
| EBITDA(a) | $-53,492 | $-64,353 | $-23,372 | $-63,795 | $-84,906 |